Fisetin: A Powerful Antioxidant for Cognitive Support and Anti-Aging
Fisetin is a naturally occurring flavonoid found in several fruits and vegetables like strawberries, apples, and cucumbers It's known for its potent antioxidant, anti-inflammatory, and neuroprotective properties, making it popular among those seeking cognitive support and anti-aging benefits.
Supplement Summary
| Name | Fisetin |
|---|---|
| Category | Antioxidants |
| Main Uses |
|
| Effectiveness | Moderate to High, depending on individual health status and goals |
| Common Dosage | 100-600 mg per day |
| Price Range | $15-30 per month |
| Forms Available | Capsules Powder |
Pros
- ✅ Potent antioxidant
- ✅ May improve cognitive function
- ✅ Potential anti-aging benefits
- ✅ Natural and plant-based
- ✅ Few reported side effects
Cons / Side Effects
- ❌ More human studies needed
- ❌ Potentially interacts with certain medications
- ❌ Not regulated by the FDA
What Is Fisetin?
How It Works
Who It's Best For
Who Should Avoid It
Dosage & Usage Tips
Buying Advice & Quality Tips
Price & Value
Final Verdict
Additional Clinical Research
RESEARCH SUMMARY: Fisetin
KEY FINDINGS:
Neuroprotection
- Fisetin, when combined with recombinant tissue plasminogen activator (rt-PA), extended the therapeutic window for treating ischemic stroke and improved patient outcomes.
- In a double-blind randomized placebo-controlled clinical trial involving 192 patients, those receiving fisetin and rt-PA showed significantly lower National Institutes of Health Stroke Scale (NIHSS) scores compared to the placebo group.
Source: Wang et al. (2019)
Anti-Aging
- Fisetin demonstrated senolytic activity, reducing senescent cell burden and extending healthspan and lifespan in aged mice.
- In a study with aged wild-type mice, intermittent fisetin treatment reduced markers of cellular senescence and improved tissue function.
Source: Yousefzadeh et al. (2018)
Inflammatory Conditions
- Fisetin was evaluated for its potential to alleviate symptoms of Gulf War Illness (GWI), a chronic multi-symptom condition.
- In a placebo-controlled, pseudo-randomized crossover trial involving 21 male veterans, fisetin did not show significant improvement in GWI symptoms compared to placebo.
Source: Hodgin et al. (2021)
RESEARCH QUALITY ASSESSMENT:
- The studies were published in peer-reviewed journals, indicating a level of credibility and scientific rigor.
- Sample sizes varied, with the stroke study involving 192 patients, providing robust data, while the GWI study had a smaller cohort of 21 participants, which may limit generalizability.
- Methodologies included randomized controlled trials and animal studies, offering a range of evidence but also highlighting the need for more extensive human trials.
- Further research is necessary to confirm these findings, especially in larger and more diverse human populations, and to explore the mechanisms underlying fisetin's effects.

